Merit Medical Sys Inc: (NASD: MMSI)

$9.97

0.02 (0.20%)

Volume 96,007

May 23 04:00 PM ET

Zacks Rank: 5-Strong Sell

Zacks Rank	Definition	Annualized Return
#1	Strong Buy	26.6%
#2	Buy	18.71%
#3	Hold	10.12%
#4	Sell	4.32%
#5	Strong Sell	2.16%
S&P	500	9.93%

Overview Quote

            Stock Activity
        
		Day Low - High
		9.79 - 10.02
	
		52wk Low - High
		9.15 - 15.37
	
		Previous Close
		9.95
	
		Avg. Volume
		317,776
	
		Industry
		MED/DENTAL-SUPP
	
		Market Cap
		423.18 M
	
		Div - Yield
		0.00 - 0.00
	
		Beta
		0.81
	
		PE (Forward)
		19.51
	
		Current Year Est.
		0.51
	
		Quarterly Earnings ESP 
		0.00%
	
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

                Premium research
            
		Zacks Rank  Short-Term: 1-3 Months
                                                                
                                                                Zacks #1 Rank Strong Buys
                                                                
                                                            This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below. 

                                                                        Zacks Rank
                                                                        Definition
                                                                        Annualized Return
                                                                    
                                                                        #1
                                                                        Strong Buy
                                                                        26.6%
                                                                    
                                                                        #2
                                                                        Buy
                                                                        18.71%
                                                                    
                                                                        #3
                                                                        Hold
                                                                        10.12%
                                                                    
                                                                        #4
                                                                        Sell
                                                                        4.32%
                                                                    
                                                                        #5
                                                                        Strong Sell
                                                                        2.16%
                                                                    
                                                                        S&P
                                                                        500
                                                                        9.93%
                                                                    
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
                                                        
		5
NA

		Zacks Recommendation  Long-Term: 6+ Months
                                                                
                                                                All Outperform Rated Stocks
                                                                
                                                            Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.
The Zacks Recommendations are split into 3 groups: Buy, Hold and Sell. Our Buy recommendations have generated returns of 34.4% in 2006, and 16.69% in 2007. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock.    More on these reports below.

                                                                    Difference Between Zacks Rank and Zacks Recommendation

                                                                    Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations
                                                                
		Neutral
	
		Zacks Industry Rank Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.
When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

                                                                About Zacks Industry Rank

                                                                Zacks Industry Rank - All current industry ranks. 

                                                                Zacks Premium - The only way to get access to the Zacks Industry Rank
                                                            
		121 out of 265
	
		Equity Research Report The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

                                        Zacks Equity Research Home
                                        Zacks Premium - The only way to get access to Zacks Recommendations
                                    
Updated as of 05/8/2013

		PREMIUM
	
    (  = Change in last 30 days) 
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial 
Zacks Premium Home | Zacks Rank Stock Education

                Key Earnings Data
            
                            PE (Forward)
                            19.51
                        
                            PEG Ratio
                            1.42
                        
                            Current Year Est.
                            0.51
                        
                            Current Quarter Estimate
                            0.12
                        
                            Most Accurate Estimate
                            0.12
                        
                            Earnings ESP 
                            0.00%
                        
                            Next Earnings Report Date
                            07-25-2013
                        
                            EPS Last Year
                            0.66
                        
                            Expected Earnings Growth
                            13.75%
                        
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

            Company Description
        
Merit Medical Systems, Inc. was formed for the purpose of producing single-use medical products of high quality and superior value primarily for use in diagnosis and treatment of cardiovascular disease.  The company's products are designed to provide physicians and other health care professionals with devices that enable them to perform interventional and diagnostic procedures safely and effectively.   
Full MMSI Company Report

        
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

            Interactive Java Charting | Fundamental Charts
        
            <a href="#"><img id="dart_image_1" src="http://b7d61a7c6b8c307bf531-a92a66b9587e2a0aa805bd4e70b98407.r95.cf2.rackcdn.com/images/zacks/logos/zacks_logo_230x76.png" width="336" height="280" border="0" alt="" /></a>        
Turn Earnings Surprises into quick profits.
 
MMSI Chart  by YCharts

Earnings Estimates

	Current Qtr (06/2013)	Next Qtr (09/2013)	Current Year (12/2013)	Next Year (12/2014)
Average Estimate	0.12	0.13	0.51	0.63
Number of Estimates	1	1	1	1
Low Estimate	0.12	0.13	0.51	0.63
High Estimate	0.12	0.13	0.51	NA
Year Ago EPS	0.21	0.20	0.72	0.51
EPS Growth	-42.86%	-35.00%	-29.17%	23.53%

More MMSI Estimates

Average Earnings Estimates for MMSI

EPS Growth for MMSI

Industry Analysis

Name	Symbol	Previous Close
MERIT MEDICAL	MMSI	9.95
LUXOTTICA ADR	LUX	54.12
ALPHATEC HLDGS	ATEC	1.91
CONMED CORP	CNMD	33.28
COOPER COS	COO	107.22
MWI VET SUPPLY	MWIV	120.00
STERIS CORP	STE	45.03
WEST PHARM SVC	WST	67.34
ALIGN TECH INC	ALGN	37.30
BARD C R INC	BCR	105.28

Sector:Medical>> Industry:MED/DENTAL-SUPP

COMPARE TICKER vs. Its Peers

Zacks Commentary

Ericsson Downgraded to Neutral

Apr 09, 2013

Bearish MACD for Merit Medical Systems, Inc.

Mar 11, 2013

Bearish MACD for Merit Medical Systems, Inc.

Feb 27, 2013

DGX Downgraded to Underperform

Feb 05, 2013

LIFE Beats 4Q Rev, Misses EPS

Feb 05, 2013

Angio Closes Microsulis Deal

Feb 04, 2013

Omnicell Beats with Record Numbers

Feb 01, 2013

CR Bard Squarely Beats Estimates

Feb 01, 2013

More MMSI Zacks Commentary

Financials

EPS TTM	0.66
Sales	394
Net Income	15
Price/Earnings	15.08
Price/Book	1.10
Price/Cash Flow	7.94
Price/Sales	1.05

More MMSI Financials

News

ANH, MMSI, CPHD, PXP, CASY, GRT Are Seasonally Ripe To Go Up In the Next Five Weeks - M2

May 17, 2013

Alpha PRO Tech has the Lowest Price to Book Ratio in the Health Care Supplies Industry (APT, MMSI, RTIX) - Financial News Network Online - News Corner

May 16, 2013

Benzinga`s Top Initiations - Benzinga

May 9, 2013

UPDATE: Benchmark Company Initiates Merit Medical Systems with Hold on Limited Visibility - Benzinga

May 9, 2013

Merit Medical to Present at UBS Global Healthcare Conference - Globenewswire

May 7, 2013

Stock Investors Bid Up Shares of Merit Medical Systems, Up 1.7% - Financial News Network Online - Market Movers

May 7, 2013

Brazilian Interventional Cardiology Devices Market 2013 - M2

May 2, 2013

Merit Medical Systems Shares Climbing Higher, Up 2.1% - Financial News Network Online - Market Movers

May 2, 2013

See All News Stories on MMSI

Broker Recommendations

Current ABR	2.00
ABR (Last Week)	2.00
# of recs in ABR	5
Average Target Price	14.83
Industry Rank by ABR	121 out of 265
Rank in Industry	28 out of 29

More MMSI Broker Recommendations

Day Low - High	9.79 - 10.02
52wk Low - High	9.15 - 15.37
Previous Close	9.95
Avg. Volume	317,776
Industry	MED/DENTAL-SUPP
Market Cap	423.18 M
Div - Yield	0.00 - 0.00
Beta	0.81
PE (Forward)	19.51
Current Year Est.	0.51
Quarterly Earnings ESP	0.00%

PE (Forward)	19.51
PEG Ratio	1.42
Current Year Est.	0.51
Current Quarter Estimate	0.12
Most Accurate Estimate	0.12
Earnings ESP	0.00%
Next Earnings Report Date	07-25-2013
EPS Last Year	0.66
Expected Earnings Growth	13.75%

Username: Password:

Remember me [?]

Merit Medical Sys Inc: (NASD: MMSI)

$9.97

0.02 (0.20%)

Volume 96,007

May 23 04:00 PM ET

Stock Activity

Premium research

Zacks Rank Short-Term: 1-3 Months

Zacks Recommendation Long-Term: 6+ Months

Zacks Industry Rank

Equity Research Report

Key Earnings Data

Company Description